GRASP age at death with kuru exposure, cognitive response to topiramate treatment as measured by the animals cognitive test, hdl cholesterol, hip bone mineral density (bmd), hypertriglyceridemia, irritible bowel syndrome, late onset alzheimers disease, resistance to kuru in aged women despite likely exposure, rheumatoid arthritis, sporadic creutzfeldt-jakob disease, systolic blood pressure (sbp)